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CEREBRAL MASS LESION DUE TO CYTOMEGALOVIRUS IN A PATIENT WITH AIDS:
CASE REPORT AND LITERATURE REVIEW
José E. VIDAL, Rafi F. DAUAR, Augusto C. PENALVA de OLIVEIRA, João F.G.S. COELHO & Diogo L.M. LINS
SUMMARY
Cytomegalovirus (CMV) disease in acquired immunodeficiency syndrome (AIDS) patients most commonly presents as
chorioretinitis and gastro-intestinal infection. Neurological involvement due to CMV may cause several clinical presentations:
polyradiculitis, myelitis, encephalitis, ventriculo-encephalitis, and mononeuritis multiplex. Rarely, cerebral mass lesion is described.
We report a 39 year-old woman with AIDS and previous cerebral toxoplasmosis. She presented with fever, seizures, and vulval ulcers.
Her chest X-ray showed multiple lung nodules, and a large frontal lobe lesion was seen in a brain computed tomography scan. She
underwent a brain biopsy through a frontal craniotomy, but her condition deteriorated and she died in the first postoperative day.
Histopathological studies and immunohistochemistry disclosed CMV disease, and there was no evidence of cerebral toxoplasmosis,
bacterial, mycobacterial or fungal infection. CMV disease should be considered in the differential diagnosis of cerebral mass lesion
in AIDS patients. High suspicion index, timely diagnostic procedures (surgical or minimally invasive), and proper utilization of
prophylactic and therapeutic medication could improve outcome of these patients.
KEYWORDS: Cerebral mass lesion; Focal brain mass; Intracranial mass lesion; Focal neurological disease; Cytomegalovirus;
Acquired immunodeficiency syndrome.
INTRODUCTION
Introduction of highly active antiretroviral therapy (HAART) has
resulted in a dramatic improvement of the course and prognosis of
acquired immunodeficiency syndrome (AIDS)-related disorders. In most
developed countries and in Brazil, where treatment is widely available,
it has dramatically reduced mortality in AIDS patients19. In HAART era,
the occurrence of central nervous system opportunistic diseases, including
cytomegalovirus encephalitis, also are decreasing14. However,
neurological complications still remain an important cause of death and
disability in human immunodeficiency virus (HIV)-infected patients14,30.
CMV disease in AIDS patients is a late event and its occurrence
seems to be an independent predictor of death11. Besides retinitis, another
five classical neurological presentations have been described:
polyradiculitis, myelitis, encephalitis, ventriculoencephalitis, and
mononeuritis multiplex4,13,15,18,20,21. Rarely, cerebral mass lesions due to
CMV have been reported21.
We report a fatal case of CMV disease mimicking a central nervous
system tumor in an AIDS patient and review of the literature.
CASE REPORT
A 39 year-old woman was diagnosed with cerebral toxoplasmosis
and AIDS in July 1998. After treatment with sulfadiazine, pyrimetamine
and folinic acid, there were complete radiological and clinical resolution,
and she was discharged home.
In September 1998, the patient was readmitted with a 2-week history
of fever, seizures, mild dificulty speaking and diminished psychomotor
activity. Physical examination disclosed a pale and drowsy woman whose
temperature was 38.2 °C. She had hepatosplenomegaly and vulval ulcers.
The rest of the exam was unremarkable. Laboratory revealed hemoglobin
= 9.7 mg/dL, leukocytes = 2800 cells/mm3 (72% neutrophils, 15%
lymphocytes, 13% monocytes). Biochemical tests disclosed AST = 32
UI, ALT = 62 UI, and alkaline phosphatase = 364 UI. Chest radiograph
showed disseminated nodular images. Chest CT scan confirmed this
finding. A transbronchial lung biopsy was performed but was
inconclusive. Brain CT scan showed a single left frontal lesion that
enhanced heterogeneously circumscribed by intense edema and that
shifted the midline (Fig. 1). Serological studies (IgG antibodies) for
cytomegalovirus, Toxoplasma gondii, and herpes simplex virus virus
were positive. CD4+ T-lymphocyte counts was 8 cells/µL (2.8%).
Fundoscopic examination was normal. The patient was treated with
sulfadiazine, pyrimethamine, folinic acid, dexamethasone, and acyclovir.
Three weeks after, the brain lesion showed just a slight decrease in
perilesional edema. Nonetheless, the vulval lesions healed. She underwent
a brain biopsy through a frontal craniotomy, but her condition deteriorated
and she died in the first postoperative day due to disseminated
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intravascular coagulation. Permission for autopsy was refused.
Pathological examination of the brain biopsy showed a granulomatous
inflammatory reaction, giant cells containing intra-cytoplasmatic and
intra-nuclear inclusions. The involvement of central nervous system due
to CMV was confirmed using immunohistochemistry. There was no
evidence of toxoplasmosis, bacterial, mycobacterial or fungal disease.
DISCUSSION
In the AIDS era, we reviewed the literature from 1981 to 2002 using
the MEDLINE database (National Library of Medicine, Bethesda, MD).
Additionally, we also searched manually in journals. The key word used
were cerebral mass lesions, focal brain lesion, intracranial mass lesion,
cytomegalovirus, and acquired immunodeficiency syndrome.
We found only seven case reports of cerebral mass lesions due to
CMV5,10,16,24. Table 1 lists the main features of these cases, including our
patient.
Despite being extremely rare in the central nervous system,
pseudotumoral forms of cytomegalic inclusion disease have already been
described in the gastrointestinal tract12,28, larynx31, submandibular
glands29, and lungs22,23,27.
Histopathological studies have found CMV encephalitis in up to
30% of AIDS patients, but there is not a good clinical and pathological
correlation7,16,21,24. Moreover, no correlation was found between presence
or severity of microglial nodules and ante mortem neurological cognitive
impairment26.
Neurological presentation of intracranial mass due to CMV was
similar to other causes of intracranial mass lesions, including cerebral
toxoplasmosis and primary lymphoma central nervous system, the most
common causes of cerebral mass lesions in AIDS patients. In some cases,
this fact justified anti-toxoplasmic therapy, with the consequent diagnosis
delay. For this reason, the history5,11,16 or concomitant CMV disease in
another organ11,24 should be considered in the initial approach of patients
with AIDS and focal brain lesions, and rise the suspicion index of CMV.
Current algorithms advise empirical treatment for T. gondii in AIDS
patients with brain mass lesions2. Stereotactic biopsy is warranted if
after 10-14 days of treatment there is no clinical or tomographic
improvement. However, under some circumstances, this protocol may
be curtailed, such as in cases of negative serological studies for T. gondii,
single lesion on MRI or when therapeutically indicated2. Some of the
reported cases were serologically negative for toxoplasmosis5,10,16.
BASSIL & WILLIAM5 reported a case where the patient had already
suffered from CMV retinitis and whose serological studies were negative
for toxoplasmosis. On the fifth hospital day, the patient underwent a
stereotactic biopsy that confirmed a cerebral focal lesion due to CMV
thus allowing early diagnosis and successful treatment. This case suggests
that a high suspicion index should raise the possibility of early surgery.
Neuroimaging studies are usually unhelpful in diagnosis suspicion
of intracranial mass in AIDS patients. The findings of cerebral mass
lesions due to CMV are non specific and cannot be differentiated of
another causes of intracranial mass lesions. Seven patients had single
lesions5,10,16,24 and only one patient had two lesions. However, a previous
CT scan had disclosed a single one24. Three patients had frontal lobe
lesions10,24. Four patients had extensive lesions that enhanced and caused
midline shift. One patient had a hemorrhagic lesion associated with a
severe expansive effect10 and another one had just an increased focal
attenuation coefficient, slight edema, and heterogeneous enhancement5.
CMV disease usually occurs in patients with very low CD4+
T-lymphocyte counts (< 50 cell/µL). Similarly, the mean of CD4+
T-lymphocyte counts of patients with intracranial mass lesion due to
CMV was 22 cells/µL (range, 8 - 81 cells/µL).
In the last years, new techniques in imaging and molecular methods
have been added to the management of AIDS patients suffering from
brain focal lesions. This improvement has led to a reduction in the number
of brain biopsies giving way to minimally invasive approaches1. Several
research studies have demonstrated the value of the polymerase chain
reaction (PCR) made in cerebrospinal fluid (CSF) for the diagnosis of
CMV disease1,8,30. This test sensitivity varies from 33% to 100%, and its
specificity from 42% to 100%. Most studies report sensitivity in excess
of 80% and specificity higher than 90%30. Two of the reported cases
were PCR reactive in CSF10,24. This approach is limited in cases where
lumbar punctures are contraindicated, as in our case.
Some patients initially improved10,24 just to get worse later due to
exacerbation or recurrence, pointing to the need of more prolonged
treatment plans. However, two cases5,16 worsened in spite of the use of
prophylactic oral ganciclovir. This finding coincides with another one
drawn from a five patients study where usual doses of ganciclovir were
incapable of avoiding or treating neurological complications when it is
used primarily to treat chorioretinitis6. A small study of patients that
Fig. 1 - Cranial CT scan showing a large contrast-enhancing lesion in the left frontal area
with extensive perilesional edema (arrow).
VIDAL, J.E.; DAUAR, R.F.; PENALVA de OLIVEIRA, A.C.; COELHO, J.F.G.S. & LINS, D.L.M. - Cerebral mass lesion due to cytomegalovirus in a patient with AIDS: case report and
literature review. Rev. Inst. Med. trop. S. Paulo, 45(6):333-337, 2003.
335
Table 1
Details of reported cases of cerebral mass lesions due to cytomegalovirus in patients with AIDS
Patient Age / Sex Prior history Clinical Brain CD4+ Diagnosis Treatment Outcome
(Ref.) of CMV presentation CT / MRI cells / µL
[year] infection
1 32 / M Yes Fever, seizures, Single 81 Brain Ganciclovir Died 3 months
(10) (disseminated bilateral limb hemispheric biopsy after diagnosis
[1995] disease) weakness  lesion
2 31 / M Not Fever, seizures, Single 14 PCR on CSF Ganciclovir Died 5 months
(10) confusion, hemispheric and then after onset of
[1995] myelopathy, lesion Foscarnet symptoms
Pneumonitis, retinitis
3 39 / M NA Fever, headache, Two 10 Brain biopsy Foscarnet Died 10 weeks
(24) hemiparesis, hemispheric and PCR on after onset of
[1996] frontal lobe lesions CSF symptoms
syndrome
4 34 / M Not Headache, Single 9 Brain biopsy Foscarnet and Died 6 months
(24) hemiparesis, hemispheric then Ganciclovir after onset of
[1996] aphasia, retinitis, lesion symptoms
colitis
5 31 / M Yes Headache, Single 10 Brain biopsy Ganciclovir Alive 4 months
(5) (retinitis) hemiparesis, hemispheric after discharged
[1997] dificulty speaking lesion from hospital
6 35 / M Not Psychomotor Single 20 Brain biopsy Ganciclovir and Died after 4½
(16) slowing, facial palsy, hemispheric then foscarnet months of
[1997] hemiparesis, gait lesion diagnosis
difficulties
7 51 / M Yes (colitis) Headache, Single NA Necropsy Without Died 4 weeks
(16) hemiparesis, cerebelar treatment after admission
[1997] cerebelar syndrome, lesion
disseminated
infection
Our 39 / F Not Fever, seizures, Single, 8 Brain biopsy Without Died 4 weeks
patient psychomotor slowing, hemispheric treatment after admission
pulmonary mass, lesion
perivaginal ulcers
NOTE. NA, not available; M, male; F, female; CMV, cytomegalovirus; CT, computed tomography; MRI, magnetic resonance imaging; CSF, cerebrospinal fluid;
PCR, protein chain reaction.
received solid organ transplantation25 concluded that combined antiviral
therapy with ganciclovir and foscarnet are safe and could possibly benefit
those patients harboring ganciclovir-resistant strains. Moreover,
combined use of ganciclovir and foscarnet could be more aggressive
therapeutic approach due to their presumed synergy9. Considering these
aspects, some authors suggest the use of combined therapies for central
nervous system CMV involvement8,20. Interestingly, the only survivor5
from the reported cases of cerebral mass lesions due to CMV, had used
ganciclovir to treat a neurological complication. The good outcome may
be attributed to the early diagnosis, timely treatment, and intravenous
secondary prophylaxis.
Current guidelines recommend interventions to prevent recurrences
of cytomegalic chorioretinitis, namely, parenteral or oral ganciclovir,
parenteral foscarnet or ganciclovir combined with foscarnet17. Concerning
the late diagnosable intracranial mass lesions, it seems reasonable the
use of combined therapy in spite of the additive toxicity. This approach
justifies itself when we face the poor prognosis of almost all cases
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reported. As occurs in other different neurological syndromes observed
in AIDS patients, a limited lifespan is anticipated, in general 1-7
months20,21.
We concluded that CMV disease should be always considered in the
differential diagnosis of intracranial mass lesions in AIDS patients, mostly
in those severely immunodepressed and previous or concomitant
cytomegalic infection in other organ. High suspicion index, timely
diagnostic procedures (surgical or minimally invasive), and proper
utilization of prophylactic and therapeutic medication could improve
outcome of these patients.
RESUMO
Lesão expansiva cerebral devida a citomegalovírus: relato de caso
e revisão da literatura
As doenças causadas pelo citomegalovírus (CMV) em pacientes com
a síndrome da imunodeficiência adquirida apresentam-se principalmente
como corioretinite ou comprometimento gastrointestinal. No sistema
nervoso central, o CMV pode causar diversas síndromes clínicas:
poliradiculite, mielite, encefalite, ventrículo-encefalite e mononeurite
múltipla. Raramente, lesões expansivas cerebrais são descritas. Os autores
relatam o caso de uma paciente de 39 anos com antecedentes de infecção
pelo HIV e toxoplasmose cerebral, que apresentou-se com febre,
convulsões e úlceras vulvares. O raios-X de tórax demonstrou múltiplos
nódulos pulmonares e a tomografia computadorizada de crânio
evidenciou extensa lesão no lobo frontal esquerdo. Após ser submetida
à craniotomia, evoluiu com piora clínica, falecendo no primeiro dia de
pós-operatório. Os estudos histopatológicos e imunohistoquímicos
demonstraram doença citomegálica. Foram excluídas toxoplasmose
cerebral e infecção bacteriana, micobacteriana ou fúngica. Concluímos
que, embora seja extremamente raro, o CMV deve ser considerado no
diagnóstico diferencial das lesões expansivas cerebrais em pacientes com
infecção pelo HIV. Um elevado índice de suspeita, procedimentos
diagnósticos oportunos (cirúrgicos ou minimamente invasivos), e o
adequado uso de antivirais (terapêuticos e profiláticos) podem melhorar
o prognóstico desta letal manifestação.
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